Enterobacteriaceae Infections: Clinical Trials

2 trials for Enterobacteriaceae Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Enterobacteriaceae Infections: new trials by email Literature Review of Enterobacteriaceae Infections trials Research Report on Enterobacteriaceae Infections

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo - Shigella
Phase 2TerminatedUniversity of Maryland, Baltimore202010-01-012021-04-29
Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb
CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a - Shigella
Phase 2TerminatedUniversity of Maryland, Baltimore202010-01-012021-04-29

Narrower conditions

Dysentery, Bacillary (2)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Digestive System Diseases (2)  ·  Dysentery (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Gram-Negative Bacterial Infections (2)  ·  Infections (2)  ·  Intestinal Diseases (2)

Interventions

Vaccines (1)

Sponsors

University of Maryland, Baltimore (2)

Countries

United States (2)

Top investigators

Karen L Kotloff, M.D. (2)